A Study to Explore Pharmacokinetic Interaction Between Rilpivirine and Metformin in Healthy Participants
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effect of steady-state (constant concentration of
medication in the blood) rilpivirine on pharmacokinetics (how a single dose of metformin is
absorbed in the body, distributed within the body, and removed from the body) of a single
dose of metformin, over time, in healthy adult participants.